WashU Medicine taps Madhusmita Misra to lead pediatrics at St. Louis Children’s Hospital
WashU Medicine has selected Madhusmita Misra, MD, to lead one of its most visible pediatric posts, naming her chair of the Edward Mallinckrodt Department of Pediatrics and pediatrician-in-chief at St. Louis Children’s Hospital. The appointment takes effect Jan. 4, 2027, placing her at the center of both academic pediatrics and hospital-based children’s care in St. Louis.
The dual role matters because pediatrics at an academic medical center is never confined to a single function. Department chairs shape faculty recruitment, research priorities, resident and fellow training, and the clinical direction of subspecialty care. In parallel, a pediatrician-in-chief sets the tone for bedside practice, continuity of care, and the link between a children’s hospital and the medical school that feeds it with trainees and investigators.
Misra arrives from the University of Virginia School of Medicine, where she serves as chair of pediatrics and physician-in-chief at UVA Health Children’s Hospital. Her move signals continuity in a leadership trajectory that has already placed her in responsibility for both academic governance and pediatric clinical operations. Institutions usually reserve this type of appointment for leaders who can move between scholarly medicine and the day-to-day pressures of a children’s hospital without treating them as separate worlds.
A leadership handoff with academic and bedside consequences
WashU Medicine is bringing in a leader who already operates at the intersection of education, research, and care delivery. That matters in pediatrics, where the needs of infants, children, and adolescents often demand tightly coordinated work across subspecialties, nursing teams, therapy services, and emergency and inpatient programs. A department chair in this setting does more than oversee an administrative unit; the office influences how quickly a hospital can adapt to emerging pediatric needs, recruit physicians with the right expertise, and maintain a pipeline of clinical teaching.
Misra will succeed Mark Lowe, MD, PhD, who has served as interim department chair since April 2026. Interim leadership often stabilizes a department during a search, but it also keeps the organization in a holding pattern. The arrival of a permanent chair usually marks the point at which long-range planning becomes easier to execute, from faculty structure to research coordination to clinical program development.
The appointment also binds WashU Medicine more tightly to St. Louis Children’s Hospital, where the pediatrician-in-chief role carries direct responsibility for clinical identity and standards. For a children’s hospital, that role shapes how care is organized around complex pediatric disease, chronic conditions, preventive medicine, and the transition from childhood to adolescence. Families may never see the organizational chart, but they feel its effects in appointment access, team coordination, and the consistency of specialist care.
Why pediatric department chairs shape more than administration
Leadership in pediatrics tends to carry outsized influence because the field spans developmental medicine, acute care, chronic disease management, and highly specialized subspecialty practice. A chair has to support everything from general pediatric outpatient care to intensive inpatient services while keeping the academic mission alive. Research programs in pediatrics often depend on stable leadership because funding, staffing, and trainee mentorship all hinge on a leader who can protect time for scholarship and clinical innovation.
Misra’s background suggests she is being asked to steer exactly that kind of integrated mission. At UVA, she has already held responsibility for both the academic department and the children’s hospital clinical enterprise. That experience is relevant at WashU Medicine, where the pediatrics chair must function as both strategist and clinician-administrator. Pediatric systems are especially sensitive to leadership continuity because they depend on long-term relationships with trainees, subspecialists, community physicians, and families.
A smooth transition in this type of appointment can affect more than internal governance. Recruitment of pediatric faculty often depends on whether candidates believe a department has a coherent vision, resources for growth, and a leader who can advocate effectively within a larger health system. Research productivity, too, often tracks with leadership stability, particularly in fields that require multidisciplinary teams and sustained follow-up over years rather than months.
Misra’s start date in early 2027 leaves a long runway before she formally assumes the role. In practical terms, that interval gives both institutions time to plan the transition, align responsibilities, and manage succession. It also gives WashU Medicine a chance to define the priorities that will sit at the top of the agenda when she arrives: faculty development, clinical integration, pediatric subspecialty growth, and the academic mission of the department.
What the appointment signals for St. Louis pediatrics
For St. Louis Children’s Hospital, the pediatrician-in-chief title links bedside care to the broader academic engine of WashU Medicine. That connection can matter most in children with complicated or rare conditions, where access to specialty expertise and research-informed care often determines how efficiently treatment moves forward. Pediatric hospitals rely on leaders who can preserve clinical excellence while also keeping education and discovery close to patient care.
The choice of a current department chair from another major academic center also suggests that WashU Medicine is looking for a leader already accustomed to high-level institutional demands. Pediatric chairs typically have to answer to multiple constituencies at once: hospital executives, medical school leadership, faculty, trainees, and the families who depend on the system. Few appointments sit closer to the core of an academic children’s hospital than this one.
No clinical program changes were detailed in the appointment announcement, and no new pediatric service lines, staffing shifts, or research initiatives were described. Even so, leadership changes of this kind often set the tone for the next phase of institutional growth. The real test will come after Misra takes office, when the department’s priorities, staffing structure, and clinical focus become visible in practice rather than in a press release.
For now, WashU Medicine has placed pediatrics in the hands of a leader with experience at a comparable academic children’s hospital, and St. Louis Children’s Hospital will gain a physician-executive expected to manage both the science and the structure of pediatric care. The appointment is scheduled, the transition is defined, and the department’s next chapter is already taking shape around a leadership handoff that will not be complete until 2027.